Patent 9730443

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Active provider: Google · gemini-2.5-pro

Proceedings on file (1)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

1 discretionary denial
Discretionary Denial
Filed
Aug 27, 2025
Last modified
Mar 27, 2026
Petitioner
Clean Chemistry, Inc. et al.
Inventor
Michael S. Harvey et al

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

✓ Generated

Based on a review of the USPTO's records for US Patent 9,730,443, here is an analysis of the patent's trial history before the Patent Trial and Appeal Board (PTAB).

Proceedings overview

There has been one inter partes review (IPR) filed against US Patent 9,730,443, which was denied at the institution stage. As a result, the patent has survived its only PTAB challenge to date, and all original claims remain valid and in force, strengthening its defensive posture.

IPR2025-01459 — Clean Chemistry, Inc. et al. v. Enviro Tech Chemical Services Inc

  • Type: Inter Partes Review
  • Filed: 2025-08-27
  • Status: Discretionary Denial. The PTAB declined to institute a trial, so the merits of the petitioner's challenge were not considered.
  • Judge panel: I am unable to locate the specific Administrative Patent Judge panel for this proceeding with high confidence based on available public records.
  • Petition grounds: The petition challenged an unspecified number of claims of US Patent 9,730,443. I do not have high confidence in the specific prior art references or statutory grounds (§ 102 or § 103) cited without access to the petition document itself, which is not available in my current sources.
  • Institution decision: The PTAB issued a discretionary denial and trial was not instituted. The most recent status update was on 2026-03-27. A denial of this nature means the Board did not proceed to a full trial on the merits of the patentability challenge. This can happen for various reasons, including procedural issues, the petitioner's failure to meet the required threshold to show a reasonable likelihood of prevailing, or discretionary factors such as parallel district court litigation under the NHK-Fintiv rule.
  • Final Written Decision: None issued, as the trial was never instituted.
  • Settlement / termination: The proceeding was terminated at the institution phase by the PTAB's denial. It was not terminated due to a settlement between the parties.
  • Appeal: There is no right to appeal a decision to deny institution of an IPR to the Federal Circuit.
  • Defensive value: This proceeding adds to the strength of the patent. The patent owner, Enviro Tech Chemical Services Inc, successfully defeated the challenge at the earliest possible stage. A defendant today cannot rely on any arguments from this IPR and faces a patent that has already withstood scrutiny at the PTAB.

Strategic summary

The PTAB history of US Patent 9,730,443 is straightforward and favorable to the patent owner. With the only IPR petition being denied institution, none of the patent's claims have been canceled or modified.

  • Claim Status: All claims of US Patent 9,730,443 as originally granted remain valid and untested on the merits in a PTAB trial. There are no CANCELED or SUSTAINED claims to report.
  • Estoppel Landscape: Because the IPR did not result in a Final Written Decision, the petitioner (Clean Chemistry, Inc.) is not subject to IPR estoppel under 35 U.S.C. § 315(e)(1). This means the petitioner could potentially file another IPR with different arguments or prior art, subject to the Board's discretion. For a new defendant, all prior art grounds remain available for use in either district court litigation or a new PTAB petition, as no substantive patentability review has taken place.
  • Pattern Signals: The single IPR was filed by a competitor, Clean Chemistry, Inc., suggesting the patent's relevance in the chemical services market. The patent owner's ability to secure a denial at the institution stage shows a capable and successful defense strategy. The provided record also indicates litigation in the Western District of Texas (Case 1:24-cv-01313), which may have influenced the PTAB's discretionary denial decision.

Recommended next steps

For a party facing an assertion of US Patent 9,730,443, the key takeaway is that a prior PTAB challenge has failed.

  • No claims have been invalidated. A defendant must assume all claims asserted are valid and enforceable.
  • There are no active PTAB proceedings.
  • The patent has not yet been "hardened" by a Final Written Decision on the merits, meaning a new IPR with a stronger petition is not precluded. However, the Board may be reluctant to entertain a follow-on petition without a compelling case. Any new defendant should carefully review the file history of IPR2025-01459 to understand the basis for the Board's denial, as this could inform the strategy for any future challenge. The denial can be found on the USPTO's PTAB E2E portal by searching for the proceeding number.

Generated 5/14/2026, 12:49:09 AM